594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

• Laetitia Fend,
• Eric Quemeneur,
• Monika Semmrich,
• Jean-Baptiste Marchand,
• Matilda Rehn,
• Nathalie Silvestre,
• Linda Mårtensson,
• Johann Foloppe,
• Ingrid Teige,
• Björn Frendeus

Affiliations

Laetitia Fend

Aff1 grid.420228.e0000 0004 0638 2273Transgene France

Eric Quemeneur

Aff4 grid.420228.e0000000406382273Transgene SA Parc d’Innovation, CS80166 67405 Illkirch-Graffenstaden Cedex France

Monika Semmrich

1BioInvent International AB, Lund, Sweden

Jean-Baptiste Marchand

2Transgene SA, Illkirch Graffenstaden, France

Matilda Rehn

1BioInvent International AB, Lund, Sweden

Nathalie Silvestre

2Transgene SA, Illkirch Graffenstaden, France

Linda Mårtensson

1BioInvent International AB, Lund, Sweden

Johann Foloppe

2Transgene SA, Illkirch Graffenstaden, France

Ingrid Teige

1BioInvent International AB, Lund, Sweden

Björn Frendeus

1BioInvent International AB, Lund, Sweden